Literature DB >> 19378203

Transplantation of oligodendrocyte progenitor cells in animal models of leukodystrophies.

Yoichi Kondo1, Ian D Duncan.   

Abstract

Leukodystrophies represent a wide variety of hereditary disorders of the white matter in the central nervous system, where the patients, mostly in infancy or childhood, suffer from progressive and often fatal neurological symptoms due to either a delay or lack of myelin development or loss of myelin. As only supportive therapies are available for the majority of the leukodystrophies, replacing genetically defective oligodendrocytes with intact oligodendrocytes by transplantation has a potential as a curative therapy. Animal models of leukodystrophies have been valuable in developing effective strategies of myelin repair in human diseases. This chapter discusses the animal models of leukodystrophies and describes methods for (a) derivation of mouse oligodendrocyte progenitor cells (OPCs) in vitro as a source of donor myelin-forming cells and (b) transplantation of OPCs into the brain and spinal cord of mouse models of leukodystrophies.

Entities:  

Mesh:

Year:  2009        PMID: 19378203     DOI: 10.1007/978-1-60327-931-4_12

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  2 in total

Review 1.  Glia: an emerging target for neurological disease therapy.

Authors:  Akshata A Almad; Nicholas J Maragakis
Journal:  Stem Cell Res Ther       Date:  2012-09-28       Impact factor: 6.832

2.  Neuroprotective effects of oligodendrocyte progenitor cell transplantation in premature rat brain following hypoxic-ischemic injury.

Authors:  Long-Xia Chen; Si-Min Ma; Peng Zhang; Zi-Chuan Fan; Man Xiong; Guo-Qiang Cheng; Yi Yang; Zi-Long Qiu; Wen-Hao Zhou; Jin Li
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.